DJIA51828.62 478.64
S&P 5007743.41 39.28
NASDAQ27068.72 129.34
Russell 20002837.55 1.98
German DAX25408.64 142.11
FTSE 10010695.25 15.26
CAC 408077.80 -3.63
EuroStoxx 506298.15 25.20
Nikkei 22566364.20 850.21
Hang Seng24510.09 -251.04
Shanghai Comp3888.37 -48.15
KOSPI7080.92 63.01
Bloomberg Comm IDX144.32 -1.62
WTI Crude-fut97.47 -2.49
Brent Crude-fut92.44 -1.85
Natural Gas3.25 -0.03
Gasoline-fut3.20 -0.12
Gold-fut4320.50 12.30
Silver-fut64.71 0.52
Platinum-fut1800.80 32.60
Palladium-fut1277.50 2.50
Copper-fut6.78 0.01
Aluminum-spot3195.00 0.00
Coffee-fut278.10 1.50
Soybeans-fut1320.00 3.50
Wheat-fut704.00 -1.75
Bitcoin84117.52 -69.89
Ethereum USD2693.28 10.46
Litecoin73.17 2.08
Dogecoin0.10 0.00
EUR/USD1.1381 -0.0007
USD/JPY158.79 0.50
GBP/USD1.3212 -0.0029
USD/CHF0.8289 0.0040
USD IDX101.04 -0.22
US 10-Yr TR5.167 0.005
GER 10-Yr TR3.6061 -0.0171
UK 10-Yr TR5.3528 -0.0129
JAP 10-Yr TR3.077 -0.005
Fed Funds4 0
SOFR3.88 0.01
High-rise commercial buildings

Sub Markets

Topics

Direct Investment  + M&As  | 
Centene to Sell Healthcare AI Platform Apixio to New Mountain Capital

Centene to Sell Healthcare AI Platform Apixio to New Mountain Capital

Centene Corporation will sell its healthcare-focused artificial intelligence (AI) platform, Apixio, to investment firm New Mountain Capital.

Acquired by Centene in December 2020, Apixio improves administrative, clinical and financial outcomes for US health plans and provider groups using its AI engine.

“Apixio has been a trusted business partner since our relationship began in 2015. As part of our ongoing portfolio review, it was important for us to find a strategic partner for Apixio with whom the business can continue to grow, innovate and thrive,” said Sarah M. London, CEO of Centene.

St. Louis, MO-based Centene expects the transaction to be neutral to 2023 adjusted EPS.

Recent deals from New York-based New Mountain include the purchase of clinical research organization Emmes from private equity investor Behrman Capital and a $2.45 billion carve out of the applied, food and enterprise services businesses of scientific research solutions major PerkinElmer.

The firm, which currently manages more than $37 billion in assets, targets high quality leaders in “defensive growth” industry sectors.

Connect

Inside The Story

Centene Corporation New Mountain Capital

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.